EG-COVII

· EyeGene Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EG-COVII, covering 2025-03-07 to 2025-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult [Phase 1, Phase 2]